Patents Assigned to ESCAPE Bio, Inc.
  • Solid forms of an S1P-receptor modulator
    Patent number: 11535632
    Abstract: This application relates to solid forms of an S1P-receptor modulator, which are useful in the treatment of diseases or disorders associated with activity of S1P, including CNS disorders.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: December 27, 2022
    Assignee: ESCAPE Bio, Inc.
    Inventors: Stéphane De Lombaert, Ana Rosario Mool Sarno, Michael A. Christie, Edward L. Ciolkowski, Susana del Rio Gancedo, Joseph Stephen Harris, Lucy Kristina Mapp, Mateusz Bogumil Pitak, Scott L. Childs
  • Indazoles and azaindazoles as LRRK2 inhibitors
    Patent number: 11427558
    Abstract: The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: August 30, 2022
    Assignee: ESCAPE Bio, Inc.
    Inventors: Albert W. Garofalo, Stéphane De Lombaert, Jacob Bradley Schwarz, Daniele Andreotti, Fabio Maria Sabbatini, Elena Serra, Silvia Bernardi, Marco Migliore, Federica Budassi, Claudia Beato